At the time of writing, Sana Biotechnology Inc [SANA] stock is trading at $1.75, up 2.34%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SANA shares have gain 8.70% over the last week, with a monthly amount drifted -32.95%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on November 05, 2024, when JMP Securities downgraded its rating to a Mkt Perform. Previously, Rodman & Renshaw started tracking the stock with Buy rating on June 26, 2024, and set its price target to $16. On January 16, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $12 on the stock. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $9 on September 25, 2023. Citigroup initiated its recommendation with a Buy and recommended $8 as its price target on September 05, 2023. In a note dated May 02, 2023, H.C. Wainwright initiated an Neutral rating.
For the past year, the stock price of Sana Biotechnology Inc fluctuated between $1.52 and $12.00. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $1.75 at the most recent close of the market. An investor can expect a potential return of 357.14% based on the average SANA price forecast.
Analyzing the SANA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.94 and Total Capital is -0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6767 points at the first support level, and at 1.6033 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8317, and for the 2nd resistance point, it is at 1.9133.
Ratios To Look Out For
It is important to note that Sana Biotechnology Inc [NASDAQ:SANA] has a current ratio of 4.47. As well, the Quick Ratio is 4.47, while the Cash Ratio is 2.7.
Transactions by insiders
Recent insider trading involved CHRISTIAN HORDO & KATHARINE HO, Officer, that happened on Dec 16 ’24 when 75000.0 shares were purchased. Former CFO, Hardy Nathan completed a deal on Nov 26 ’24 to buy 91607.0 shares. Meanwhile, Former CFO NATHAN HARDY bought 25933.0 shares on Nov 25 ’24.
